Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 1, 2011, Pages 37-49

  Li, Hong ^a   Alyce Bradbury, J ^a   Dackor, Ryan T ^a   Edin, Matthew L ^a   Graves, Joan P ^a   DeGraff, Laura M ^a   Wang, Ping Ming ^a   Bortner, Carl D ^a   Maruoka, Shuichiro ^a   Lih, Fred B ^a   Cook, Donald N ^a   Tomer, Kenneth B ^a   Jetten, Anton M ^a   Zeldin, Darryl C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Asthma; COX 2; IL 17; Prostaglandins; Th17 cell

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ICOSANOID; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; OVALBUMIN; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SMALL INTERFERING RNA; STAT3 PROTEIN;

ALLERGIC PNEUMONITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIZATION; T LYMPHOCYTE; TH17 CELL;

ANIMALS; ASTHMA; CELL DIFFERENTIATION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EICOSANOIDS; INFLAMMATION; INTERLEUKIN-17; LUNG; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; OVALBUMIN; RECEPTORS, PROSTAGLANDIN; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS;

EID: 80051558097     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201010-1637OC     Document Type: Article

References (49)

1. Adamson AS, Collins K, Laurence A, O'Shea JJ. The current status of lymphocyte signaling: new roles for old players. Curr Opin Immunol 2009;21:161-166.
2. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fili L, Ferri S, Frosali F, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849-1861. (Pubitemid 47240944)
3. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Human Th17 cells: are they different from murine Th17 cells? Eur J Immunol 2009;39:637-640.
4. Manel N, Unutmaz D, Littman DR. The differentiation of human Th17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORγt. Nat Immunol 2008;9:641-649. (Pubitemid 351714729)
5. Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008;226:57-79.
6. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 2008;180:5625-5635.
7. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003;113:1803-1812. (Pubitemid 37210986)
8. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:430-438. (Pubitemid 32881066)
9. Chandler DB, Fulmer JD. Prostaglandin synthesis and release by subpopulations of rat alveolar macrophages. J Immunol 1987;139:893-898. (Pubitemid 17107094)
10. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997;388:678-682. (Pubitemid 27366439)
11. Hersh EV, Lally ET, Moore PA. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Curr Med Res Opin 2005; 21:1217-1226. (Pubitemid 41140725)
12. Patel R, Attur MG, Dave M, Abramson SB, Amin AR. Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. J Immunol 1999;162:4191-4197. (Pubitemid 29314806)
13. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999;5:698-701.
14. Narumiya S. Prostanoids and inflammation: a new concept arising from receptor knockout mice. J Mol Med 2009;87:1015-1022.
15. Rocca B, Spain LM, Pure E, Langenbach R, Patrono C, FitzGerald GA. Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development. J Clin Invest 1999;103:1469-1477. (Pubitemid 29535503)
16. Carey MA, Germolec DR, Bradbury JA, Gooch RA, Moorman MP, Flake GP, Langenbach R, Zeldin DC. Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice. Am J Respir Crit Care Med 2003;167:1509-1515. (Pubitemid 37363360)
17. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, Ganea D. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23/IL-17 axis. J Immunol 2007;178:8138-8147. (Pubitemid 46898086)
18. Sheibanie AF, Khayrullina T, Safadi FF, Ganea D. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis Rheum 2007;56:2608-2619. (Pubitemid 47237279)
19. Chizzolini C, Chicheportiche R, Alvarez M, de Rham C, Roux-Lombard P, Ferrari-Lacraz S, Dayer JM. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 2008;112:3696-3703.
20. Khayrullina T, Yen JH, Jing H, Ganea D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 2008;181:721-735.
21. Newman JW, Watanabe T, Hammock BD. The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS. J Lipid Res 2002;43:1563-1578.
22. Wang YH, Liu YJ. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 2008;20:697-702.
23. Gavett SH, Madison SL, Chulada PC, Scarborough PE, Qu W, Boyle JE, Tiano HF, Lee CA, Langenbach R, Roggli VL, et al. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J Clin Invest 1999;104:721-732. (Pubitemid 29536357)
24. Thivierge M, Rola-Pleszczynski M. Up-regulation of inducible cyclooxygenase gene expression by platelet-activating factor in activated rat alveolar macrophages. J Immunol 1995;154:6593-6599.
25. Rahmouni S, Aandahl EM, Nayjib B, Zeddou M, Giannini S, Verlaet M, Greimers R, Boniver J, Tasken K, Moutschen M. Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochem J 2004;384:469-476. (Pubitemid 40018960)
26. Mahic M, Yaqub S, Johansson CC, Tasken K, Aandahl EM. Foxp3+cd4+cd25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 2006;177:246-254. (Pubitemid 43939136)
27. Avalos AM, Latz E, Mousseau B, Christensen SR, Shlomchik MJ, Lund F, Marshak-Rothstein A. Differential cytokine production and bystander activation of autoreactive B cells in response to cpg-a and cpg-b oligonucleotides. J Immunol 2009;183:6262-6268.
28. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19:652-657. (Pubitemid 350236805)
29. Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, McKenzie BS, Kastelein RA, Cua DJ, de Waal Malefyt R. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009;206:535-548.
30. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007;19:409-417. (Pubitemid 351274050)
31. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852. (Pubitemid 46697925)
32. Bettelli E, Oukka M, Kuchroo VK. Th17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-350. (Pubitemid 46745409)
33. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 2006;6:329-333.
34. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. Human Th17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13:1173-1175. (Pubitemid 47530640)
35. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007;204:2803-2812. (Pubitemid 350179551)
36. Sousa A, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M, Lee TH. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997;52:940-945. (Pubitemid 27514487)
37. Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-2168. (Pubitemid 16149701)
38. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645-648. (Pubitemid 16037670)
39. Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K, Sugimoto Y, Narumiya S. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 2009;15:633-640.
40. Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 2007;178:6730-6733. (Pubitemid 46847396)
41. Nakata J, Kondo M, Tamaoki J, Takemiya T, Nohara M, Yamagata K, Nagai A. Augmentation of allergic inflammation in the airways of cyclooxygenase-2- deficient mice. Respirology 2005;10:149-156. (Pubitemid 40637997)
42. Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML. Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001;97:3466-3469.
43. Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 2004;18:1318-1320. (Pubitemid 39561589)
44. Lo HW, Cao X, Zhu H, Ali-Osman F. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-Stat3 and EGFRvIII-Stat3 signaling axes. Mol Cancer Res 2010;8:232-245.
45. Delerive P, Monte D, Dubois G, Trottein F, Fruchart-Najib J, Mariani J, Fruchart JC, Staels B. The orphan nuclear receptor RORalpha is a negative regulator of the inflammatory response. EMBO Rep 2001;2:42-48. (Pubitemid 32229720)
46. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, et al. Cutting edge: an in vivo requirement for stat3 signaling in Th17 development and Th17-dependent autoimmunity. J Immunol 2007;179:4313-4317.
47. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+T helper cells. Cell 2006;126:1121-1133. (Pubitemid 44380299)
48. Han C, Demetris AJ, Stolz DB, Xu L, Lim K, Wu T. Modulation of stat3 activation by the cytosolic phospholipase A2α and cyclooxygenase-2- controlled prostaglandin E2 signaling pathway. J Biol Chem 2006;281: 24831-24846. (Pubitemid 44274256)
49. Lo RK, Liu AM, Wise H, Wong YH. Prostacyclin receptor-induced stat3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling. Cell Signal 2008;20:2095-2106.